An update on semaglutide for CKD in the presence of T2D

1 minute read


Prof Richard MacIsaac provides an update on the chronic kidney disease (CKD) indication for semaglutide, explains the PBS criteria and how healthcare professionals can initiate this GLP-1 RA.


This content is for AHPRA registered professionals only.
Join Now

End of content

No more pages to load

Log In Register ×